The uveitis treatment market across seven major economies—the USA, France, Germany, Italy, Spain, the UK, and Japan—is projected to grow from $522 million in 2023 to $1.5 billion by 2033, according to ...

In the USA, the layoffs at health agencies, proposed tariffs on imports and other disruptive policies under President Donald ...

Myricx Bio, a UK biotech focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates ...

Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

US biopharma Rhythm Pharmaceuticals has announced positive topline results from the pivotal Phase III TRANSCEND trial evaluating setmelanotide, a melanocortin-4 receptor (MC4R) agonist, for the ...

Indian drugmaker Sun Pharmaceutical Industries (BSE: 524715) revealed it has launched fexuprazan tablets 40mg in India under ...

Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

At the recent AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Disease (PD), Cerevance announced that solengepras, a first-in-class G-protein coupled receptor 6 (GPR6) antagonist in ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

Australia’s Therapeutics Goods Administration (TGA) has issued a safety notice on isotretinoin, originally sold as Roaccutane ...

The USA’s Centers for Medicare & Medicaid Services (CMS) yesterday released the Calendar Year (CY) 2026 Rate Announcement for ...